it's also acting in the brain." The researchers didn't stop there
For detailed month-by-month expectations on semaglutide, check out our complete guide to semaglutide weight loss results
My colleague and Audience Strategy and Data Innovation expert Amanda Patterson said, The rise in GLP-1 medications is fundamentally reshaping not just how people eat, but what and how much they buy at the grocery store
Understanding The Weight Loss Industry Today A report from IQVIA Institute estimates 2022 consumer spending on weight loss was nearly $2.1 billion, up from $0.5 billion in 2018
While the meds and surgery are both effective weight loss tools, researchers are still exploring the long-term effects of GLP-1 receptor agonists (GLP-1 RAs) and how best to support muscle health alongside weight loss
MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation has 346 litigants as of August 2023, an increase of 235 active cases over the past month, which is an over 200% jump in a single month